Specify a stock or a cryptocurrency in the search bar to get a summary
Microbix Biosystems Inc.
MBXMicrobix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada. Address: 265 Watline Avenue, Mississauga, ON, Canada, L4Z 1P3
Analytics
WallStreet Target Price
1.12 CADP/E ratio
8Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures MBX
Dividend Analytics MBX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History MBX
Stock Valuation MBX
Financials MBX
Results | 2019 | Dynamics |